Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana

scientific article published on 8 November 2006

Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/508865
P8608Fatcat IDrelease_fj7hajm5nzgphjbhdd2wfpmgam
P698PubMed publication ID17109297

P50authorMax EssexQ6794729
Sikhulile MoyoQ56990380
Tendani GaolatheQ91908938
Ndwapi NdwapiQ92727538
P2093author name stringAva Avalos
C William Wester
Hermann Bussmann
Richard G Marlink
Rob Roy MacGregor
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectBotswanaQ963
P304page(s)1612-1615
P577publication date2006-11-08
P1433published inClinical Infectious DiseasesQ5133764
P1476titleSerological evidence of HIV-associated infection among HIV-1-infected adults in Botswana
P478volume43

Reverse relations

cites work (P2860)
Q37415603Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges
Q35744193Cancer Incidence following Expansion of HIV Treatment in Botswana
Q55030278Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana.
Q64111522Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes
Q35183973HIV, Hepatitis B, and Hepatitis C in Zambia
Q40794632Hepatitis B vaccination of healthcare workers at the Princess Marina Hospital, Botswana
Q37792614Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis
Q42698618High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana
Q37141399Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
Q64360047Implementing a Birth Dose of Hepatitis B Vaccine in Africa: Findings from Assessments in 5 Countries
Q34189873Importance of nonenteric protozoan infections in immunocompromised people.
Q58726310In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm
Q89970158Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana
Q40797865Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana
Q57159588Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana
Q35744379Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana
Q35282729Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
Q36131256Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients
Q34982182Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya
Q35131468Prevalence of hepatitis B and hepatitis C coinfections in an adult HIV centre population in Gaborone, Botswana
Q38963371Reliability of rapid testing for hepatitis B in a region of high HIV endemicity
Q38974815Review of cytomegalovirus coinfection in HIV-infected individuals in Africa
Q37375386Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana

Search more.